Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly. 

1. STOCK NEWS: 

• PepsiCo (PEP) intends to sell Tropicana, Naked, and other select North American juice brands [more]
• Alibaba (BABA) reported mixed quarterly results and raised its stock buyback authorization [more]
  
• Bausch Health (BHC) reported quarterly results and announced a plan to pursue an IPO of its Solta Medical unit [more]
  
• Sanofi (SNY) has agreed to acquire Translate Bio (TBIO) for $38 per share in cash [more]
  
• Under Armour (UAA) provided a "beat and raise" report for Q2 [more]
  

2. WALL STREET CALLS: 

• Square (SQ) upgraded to Market Perform at Raymond James and upgraded to Outperform at Cowen day after Afterpay deal announcement [more]
• Affirm (AFRM) downgraded to Neutral from Buy at DA Davidson [more]
  
• KeyBanc upgrades Airbnb (ABNB) ahead of earnings and "material positive revision cycle" [more]
  
• Workday (WDAY) upgraded to Overweight from Equal Weight at Barclays [more]
  
• Victoria's Secret (VSCO) initiated with an Overweight at Morgan Stanley [more]
  

3. AROUND THE WEB: 

• The U.K. could block Nvidia's (NVDA) takeover of ARM on security worries, Bloomberg reports [more]
• JPMorgan (JPM) is re-evaluating its return to office policies, Fox Business says [more]
  
• Deutsche Bank (DB) intends to resume sponsoring Hong Kong IPOs, WSJ says [more]
  
• Facebook (FB) will premiere a paid movie on its platform for the first time, Axios reports [more]
  
• Goldman Sachs (GS) is raising entry-level base pay by nearly 30%, WSJ reports [more]
  

4. MOVERS: 

• Outlook Therapeutics (OTLK) increases after reporting “positive” clinical and statistically significant top-line results from its Phase 3 NORSE TWO safety and efficacy trial evaluating ONS-5010 / LYTENAVA [more]
• HollySys Automation Technologies (HOLI) rises in New York after revealing its board of directors is in the process of evaluating acquisition offers from two consortiums [more]
  
• Arcturus Therapeutics (ARCT) higher after Sanofi deal for Translate Bio, receiving approval for a clinical trial application from the Singapore Health Sciences Authority [more]
• ViacomCBS (VIAC) down after announcing multi-year distribution agreements with Cox Communications [more]
  
• Neuronetics (STIM) and Verastem (VSTM) lower after reporting quarterly results [more]
  

5. EARNINGS/GUIDANCE: 

• Eli Lilly (LLY) reiterated its FY21 earnings and revenue guidance [more]
• Take-Two (TTWO) reported upbeat quarterly results [more]
  
• Simon Property (SPG) provided a "beat and raise" report for Q2 [more]
  
• DuPont (DD) also provided a "beat and raise" report for Q2 [more]
  
• Clorox (CLX) reported lower than expected quarterly results and fiscal year guidance [more]
  

INDEXES: 

Near midday, the Dow was up 175.34, or 0.50%, to 35,013.50, the Nasdaq was up 44.07, or 0.30%, to 14,725.14, and the S&P 500 was up 22.74, or 0.52%, to 4,409.90.